Sort
48,018 grants matching “immunotherapy”
Immunoengineering Strategies for Musculoskeletal Trauma
$497,511Robert E Guldberg · University Of Oregon · R01 · FY2023 · AR
Metabolic and purinergic immune regulation
$497,500Wolfgang G Junger · Beth Israel Deaconess Medical Center · R35 · FY2021 · GM
Regulatory B cells in the amelioration of immune-mediated periodontal disease
$497,500Xiaozhe Han · Ada Forsyth Institute, Inc. · R01 · FY2019 · DE
Metabolic and purinergic immune regulation
$497,500Wolfgang G Junger · Beth Israel Deaconess Medical Center · R35 · FY2020 · GM
Investigating the Genesis of Tumor Immune Microenvironment (TIME) as a function of Inflammation
$497,352Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2023 · CA
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas
$497,320George Yancey Gillespie · Treovir, Inc · R44 · FY2020 · CA
Nanodelivery platform for antibody drugs targeting NHL
$497,264Masakazu Kamata · University Of California Los Angeles · R01 · FY2019 · CA
Cancer Center Support Grant
$497,258Timothy J Eberlein · Washington University · P30 · FY2016 · CA
Personalized Immunotherapy of Patients with Ovarian Cancer
$497,223Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Innate Immunity to Spiral Ganglion Neuron Degeneration
$497,215Tejbeer Kaur · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DC
Making and breaking CD8+ T cell self-tolerance
$497,181Stephen C Jameson · University Of Minnesota · R01 · FY2018 · AI
Role of Tspan5 in MHC I antigen presentation and cancer immune evasion
$497,167Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · AI
Signal and Transcription Factor Network interactions in Head and Neck Cancer
$497,137Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC
A HER-2/neu pulsed DC1 vaccine for patients with DCIS
$497,125Brian Joseph Czerniecki · University Of Pennsylvania · R01 · FY2012 · CA
CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS
$497,111Ninh La-Beck · Texas Tech University Health Scis Center · R01 · FY2023 · CA
NOVEL IMMUNOTHERAPY OPTIONS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
$497,000The Nemours Foundation · · FY2022 · Defense Health Agency
Mechanistic Virology Core
$496,975Kartik Chandran · Scripps Research Institute, The · U19 · FY2018 · AI
PHASE I/II TRIAL OF HOKT3(1(ALA-ALA) IN TYPE 1 DIABETES
$496,912Columbia University Health Sciences · R01 · FY2001 · DK
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
$496,844Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
Chemokine Modulation During SIV Infection & AIDS
$496,823Todd A Reinhart · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · AI
PROTEINS IN MULTIPLE MYELOMA AND RELATED BLOOD DISORDERS
$496,817Alan Solomon · University Of Tennessee Knoxville · R01 · FY2011 · CA
Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death
$496,811Clifford Cho · Van Andel Research Institute · R01 · FY2025 · CA
Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen
$496,790Antoni Ribas · California Institute Of Technology · P01 · FY2014 · CA
Acute Kidney Injury and Double Negative T Cells
$496,786Abdel Hamad · Johns Hopkins University · R01 · FY2022 · DK
PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast Cancer
$496,614David A Mankoff · University Of Pennsylvania · R01 · FY2024 · CA